Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.

Efthymia SkafidaAngeliki Andrikopoulou Evangelos TerposChristos MarkellosSavvina Moustafa Dimitrios Pectasides Meletios- Athanasios Dimopoulos Flora Zagouri Dimitrios Vassilopoulos

Published in: The breast journal (2023)

CDK4/6 inhibitors might have a protective effect against joint inflammation and arthralgia occurrence. Further studies are warranted to investigate arthralgia incidence in this population.

Keyphrases

cell cycle
oxidative stress
early stage
risk assessment
risk factors
case report
cell proliferation
case control